{"gene":"ERCC6L","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":2007,"finding":"PICH is an interaction partner and substrate of Plk1; Cdk1 phosphorylates PICH on T1063, which recruits Plk1 to PICH and controls its localization to kinetochores, inner centromeres, and inter-kinetochore threads during mitosis.","method":"Co-immunoprecipitation, phosphorylation mapping, siRNA knockdown, immunofluorescence","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP with phosphorylation site identification, replicated across multiple orthogonal methods in the foundational paper, widely cited and built upon","pmids":["17218258"],"is_preprint":false},{"year":2007,"finding":"PICH-positive inter-kinetochore threads are tension-dependent, DNase-sensitive, and exacerbated by premature cohesin loss or topoisomerase II inhibition, suggesting they represent stretched centromeric chromatin/catenated DNA.","method":"Immunofluorescence, DNase treatment, siRNA knockdown of cohesins, topoisomerase II inhibitor (ICRF-193) treatment","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal perturbations (DNase, cohesin depletion, topo II inhibition) in a single rigorous study, widely replicated conceptually","pmids":["17218258"],"is_preprint":false},{"year":2007,"finding":"Depletion of PICH causes selective loss of Mad2 from kinetochores and abrogates the spindle checkpoint; however, subsequent work showed this effect was due to off-target siRNA suppression of Mad2, not a direct PICH function in the SAC.","method":"siRNA knockdown, immunofluorescence for Mad2, rescue with Mad2-expressing BAC, multiple siRNA oligonucleotides","journal":"Cell / Chromosoma","confidence":"High","confidence_rationale":"Tier 2 / Strong — original claim (PMID 17218258) refuted by rigorous siRNA specificity analysis (PMID 19904549) using BAC rescue and multiple oligos; negative/retracted finding recorded explicitly","pmids":["17218258","19904549"],"is_preprint":false},{"year":2009,"finding":"PICH does not have a direct role in spindle assembly checkpoint (SAC) signaling; siRNAs targeting PICH that abolished the SAC also reduced Mad2 mRNA/protein as an off-target effect. siRNAs that effectively deplete PICH without affecting Mad2 do not abolish SAC functionality.","method":"siRNA specificity analysis, BAC complementation expressing murine Mad2, Plk1 depletion/inhibition rescue experiments","journal":"Chromosoma","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous siRNA specificity controls with BAC rescue, multiple orthogonal approaches disproving original claim","pmids":["19904549"],"is_preprint":false},{"year":2007,"finding":"Depletion of topoisomerase IIα leads to abnormal persistence of PICH-coated anaphase threads connecting segregating chromatids and shortening of the metaphase inter-kinetochore distance, indicating functional cooperation between PICH and topo IIα at centromeres.","method":"Conditional-lethal topo IIα mutant cell line, immunofluorescence for PICH, FISH","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, clean genetic system but single method readout for PICH phenotype","pmids":["17956945"],"is_preprint":false},{"year":2008,"finding":"PICH recruits Plk1 to chromosome arms during mitosis; disruption of the PICH-Plk1 interaction abolishes Plk1 localization on chromosome arms. Both PICH phosphorylation and its ATPase activity are required for mitotic chromosome compaction.","method":"Co-immunoprecipitation, dominant-negative PICH mutants (Plk1-binding deficient, ATP-binding deficient), immunofluorescence","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus multiple domain mutants in one lab; two orthogonal methods","pmids":["18418076"],"is_preprint":false},{"year":2010,"finding":"PICH and Plk1 coordinately maintain prometaphase chromosome arm architecture; PICH knockdown causes loss of Plk1 from chromosome arms and produces disorganized 'wavy' chromosomes with an open/X-shaped configuration that is prevented by topoisomerase II inhibitor ICRF-193, indicating the PICH-Plk1 complex maintains chromosome architecture in a topo II-dependent manner.","method":"siRNA knockdown, immunofluorescence for Plk1/condensin/cohesin, ICRF-193 treatment","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi phenotype with pharmacological rescue and multiple localization markers, single lab","pmids":["20130082"],"is_preprint":false},{"year":2011,"finding":"PICH directly binds BLM and enables BLM localization to anaphase centromeric threads. Purified recombinant PICH has nucleosome remodeling activity in vitro. PICH- or BLM-depleted cells fail to resolve anaphase threads, which then contain histones and centromere markers, forming centromeric micronuclei.","method":"Co-immunoprecipitation (PICH-BLM), RNAi knockdown, in vitro nucleosome remodeling assay with purified recombinant PICH, immunofluorescence","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro nucleosome remodeling with purified protein plus reciprocal Co-IP and RNAi phenotype, single lab but multiple orthogonal methods","pmids":["21743438"],"is_preprint":false},{"year":2012,"finding":"ATPase activity of PICH is critical for its function: an intact ATPase domain is required to prevent chromatin bridge formation but is not required for UFB resolution. ATPase activity is also required for temporal and spatial control of PICH localization to chromatin.","method":"Antibody microinjection, siRNA rescue with ATPase-mutant PICH, quantitative analysis of UFB and chromatin bridge frequencies","journal":"Chromosoma","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mutagenesis combined with rescue experiments and quantitative phenotypic readouts, single lab","pmids":["22527115"],"is_preprint":false},{"year":2012,"finding":"BLM and PICH cooperate to recruit active topoisomerase IIα to centromeres; both BLM-deficient and PICH-deficient prometaphase cells display centromere structural changes, higher centromeric non-disjunction in cohesin-free conditions, and defective topoisomerase IIα centromere recruitment.","method":"RNAi knockdown, immunofluorescence, chromatin immunoprecipitation, electron microscopy, FISH","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (ChIP, EM, FISH, IF) in single lab","pmids":["22563370"],"is_preprint":false},{"year":2013,"finding":"PICH binds duplex DNA with remarkably high affinity, and this affinity increases with tension-induced DNA stretching, mimicking the mitotic spindle on a UFB. PICH performs ATP-dependent protein translocation and extends DNA. PICH binding diminishes force-induced DNA melting.","method":"Microfluidics, single-molecule fluorescence microscopy, optical tweezers, in vitro assays with purified PICH","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro with purified protein using multiple biophysical methods (optical tweezers, single-molecule fluorescence, microfluidics) in a single rigorous study","pmids":["23973328"],"is_preprint":false},{"year":2015,"finding":"PICH directly stimulates the catalytic activity of topoisomerase II in vitro. Deletion of PICH causes chromosome structural abnormalities, hypersensitivity to topo II inhibitor ICRF-193, sister chromatid non-disjunction in anaphase, and cytokinesis failure. The timely resolution of UFBs and rDNA structures depends on the ATPase activity of PICH.","method":"PICH knockout in avian (DT40) cells and human cell line, ICRF-193 sensitivity assay, in vitro topo II activity assay with purified PICH protein","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution with purified proteins plus genetic knockout in two different cell systems with defined phenotypic readouts","pmids":["26643143"],"is_preprint":false},{"year":2015,"finding":"PICH is modified by SUMO2/3 on mitotic chromosomes and in vitro, mediated by the SUMO E3 ligase PIASy. PICH interacts with SUMOylated PARP1 and SUMOylated topoisomerase IIα. SUMOylation of PICH significantly reduces its DNA binding capability, suggesting SUMO regulates PICH ATPase activity.","method":"Xenopus egg extract assays, co-immunoprecipitation with SUMOylated substrates, in vitro SUMOylation assay with purified recombinant human PICH, DNA binding assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro biochemical assays with purified recombinant PICH plus Xenopus extract experiments and DNA binding functional readout, multiple orthogonal methods","pmids":["25564610"],"is_preprint":false},{"year":2016,"finding":"PICH contains three SUMO-interacting motifs (SIMs). SIM3 (near the C-terminus) is critical for PICH centromeric localization, while the other two SIMs function in chromatin bridge prevention. All SIMs are dispensable for PICH localization to ultrafine anaphase DNA bridges.","method":"Conditional PICH expression, SIM-deficient PICH mutants, immunofluorescence","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mutagenesis (three SIM mutations) with rescue and localization readouts, single lab","pmids":["27230136"],"is_preprint":false},{"year":2017,"finding":"PICH interacts with the BEN domain-containing protein BEND3 in human cells during mitosis via a novel TPR domain (in PICH) – BEN domain (in BEND3) interface. The crystal structure of the TPR-BEN complex was determined at 2.2 Å resolution, and structure-guided mutagenesis identified residues critical for the interaction.","method":"Co-immunoprecipitation in human cells, purification of full-length proteins, in vitro biochemical interaction assay, crystal structure at 2.2 Å (MAD phasing), structure-guided mutagenesis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation by mutagenesis and biochemical interaction assays, multiple orthogonal methods in one study","pmids":["28977671"],"is_preprint":false},{"year":2019,"finding":"PICH and Topoisomerase 3α (TOP3A) together create an extraordinarily high density of positive DNA supercoiling, analogous to a reverse-gyrase activity, driven by PICH progressively extruding hypernegatively supercoiled DNA loops that are relaxed by TOP3A.","method":"In vitro reconstitution with purified human PICH and TOP3α, magnetic tweezers single-molecule assay","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of a novel enzymatic activity with purified proteins and single-molecule biophysics","pmids":["30936532"],"is_preprint":false},{"year":2020,"finding":"Upon replication stress, PICH is recruited to stalled replication forks in a manner dependent on TOP2A SUMOylation by ZATT. PICH acts downstream of HLTF/ZRANB3/SMARCAL1 (which initiate limited fork reversal) to promote extensive fork reversal by resolving topological barriers. Disruption of the ZATT-TOP2A-PICH axis results in accumulation of partially reversed forks and enhanced genome instability.","method":"siRNA/shRNA knockdown of pathway components, replication fork reversal assay (electron microscopy), proximity ligation assay, co-immunoprecipitation","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis mapping with multiple knockdowns and EM-based fork reversal assay, plus Co-IP, multiple orthogonal methods","pmids":["33296677"],"is_preprint":false},{"year":2020,"finding":"PICH specifically disperses SUMO2/3 foci on mitotic chromosomes; this requires its DNA translocase activity. PICH uses its SUMO-binding ability to attenuate SUMOylated TopoIIα activity in vitro. Conditional depletion of PICH causes retention of SUMO2/3-modified chromosomal proteins including TopoIIα.","method":"Auxin-inducible degron (AID) PICH depletion, translocase-deficient PICH mutant rescue, in vitro TopoIIα activity assay with SUMOylated substrate, immunofluorescence","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro enzymatic assay plus AID depletion system with domain mutant rescue, multiple orthogonal methods, single lab","pmids":["32877270"],"is_preprint":false},{"year":2022,"finding":"PICH is a tension- and ATP-dependent nucleosome remodeler: under tension mimicking anaphase chromatin bridges, PICH facilitates nucleosome unwrapping and subsequently slides remaining histones along the DNA.","method":"Single-molecule assay: dual-trap optical tweezers combined with fluorescence imaging of PICH and histones on nucleosome-array constructs in vitro","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified proteins, single-molecule biophysics with direct visualization of nucleosome remodeling events","pmids":["36433994"],"is_preprint":false},{"year":2022,"finding":"PICH deficiency in mice leads to defective embryonic hematopoiesis: Pich-KO fetal liver HSCs show elevated cytoplasmic dsDNA and activation of the cGAS-STING pathway, resulting in excessive type I interferon production and apoptosis. Deletion of Ifnar1 or cGAS reverses the defective hematopoiesis.","method":"Pich knockout mouse model, HSC transplantation assay, cGAS/Ifnar1 double knockout rescue, cytoplasmic dsDNA staining, interferon quantification","journal":"Advanced science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis using double KO rescue (cGAS-KO and Ifnar1-KO), transplantation functional readout, multiple orthogonal approaches","pmids":["35037428"],"is_preprint":false},{"year":2023,"finding":"PICH forms a transcriptional complex with RNA polymerase II and ATF4 at the CCNA1 (cyclin A1) promoter in an ATPase-dependent manner, promoting cyclin A1 transcription and accelerating S-phase progression, thereby impairing 5-FU chemosensitivity in gastric cancer.","method":"Co-immunoprecipitation (PICH-PolII-ATF4), ChIP at CCNA1 promoter, ATPase-deficient PICH mutant, organoid and patient-derived xenograft assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, ChIP, domain mutant, and in vivo PDX validation in single lab; multiple methods","pmids":["37646571"],"is_preprint":false},{"year":2023,"finding":"FIRRM (C1orf112) and FIGNL1 inactivation creates synthetic lethality with PICH (ERCC6L). FIRRM interacts with and stabilizes FIGNL1; loss of either leads to UFB formation, prolonged RAD51 foci, and impaired replication fork dynamics, creating dependency on PICH for viability.","method":"Genome-wide CRISPR knockout screen, co-immunoprecipitation (FIRRM-FIGNL1), UFB imaging, RAD51 foci quantification, replication fork dynamics assay","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide screen plus co-IP and multiple functional readouts, single lab","pmids":["37347663"],"is_preprint":false},{"year":2023,"finding":"ERCC6L directly interacts with KIF4A; both proteins cooperate in mitosis and breast cancer cell progression. ERCC6L accelerates the cell cycle by regulating the G2/M checkpoint via p53/p21/CDK1/Cyclin B and PLK/CDC25C/CDK1/Cyclin B signaling pathways.","method":"Co-immunoprecipitation (ERCC6L-KIF4A), ERCC6L conditional knockout mouse model, western blotting of pathway components, cell cycle analysis","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for interaction plus conditional KO mouse and pathway western blots, single lab","pmids":["37667329"],"is_preprint":false},{"year":2024,"finding":"RAD52 deficiency increases ERCC6L-coated anaphase UFBs, and ERCC6L depletion causes elevated RAD52 foci in prometaphase and interphase cells. RAD52 and ERCC6L have a compensatory/synthetic-lethal relationship for genome stability in mitosis, enhanced by replication stress and topo IIα inhibition.","method":"Genome-wide CRISPR knockout screen, RAD52-deficient cell lines, ERCC6L depletion, UFB quantification, 53BP1 foci quantification, hydroxyurea and ICRF-193 treatment","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide screen followed by secondary validation with multiple perturbations and readouts, single lab","pmids":["39561207"],"is_preprint":false},{"year":2025,"finding":"PICH's translocase activity plays a dual role in UFB resolution: facilitating generation of single-stranded UFBs and stimulating topoisomerase IIα. A PICH mutant impairing UFB recruitment of BLM and RIF1 partially inhibits UFB resolution, while a translocase-inactive mutant (PICHK128A) completely fails to resolve UFBs and also inhibits single-stranded UFB formation and induces hypocondensed chromosomes. PICH depletion in diploid cells induces DNA damage, micronuclei, p53 activation, G1-phase delay, and chromosomal rearrangements (translocations and inversions) detected by whole-genome sequencing.","method":"PICH depletion, domain mutant rescue (translocase-inactive PICHK128A, BLM/RIF1 recruitment mutant), whole-genome sequencing, single-stranded UFB immunofluorescence, topo IIα stimulation assay","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple domain mutants with functional rescue, WGS genomic readout, and biochemical topo IIα assay; multiple orthogonal approaches in single study","pmids":["39704103"],"is_preprint":false},{"year":2025,"finding":"PICH impacts spindle assembly checkpoint (SAC) activity via both its DNA translocase activity and SUMO-interaction (SIM) activities. Defects in either PICH remodeling or SIM function delay mitotic progression by activating the SAC (extended Mad1 foci at centromeres). PICH controls Bub1 kinetochore abundance, and loss of PICH leads to increased Bub1 at kinetochores, implicating PICH in SAC regulation through SUMOylated chromosomal protein remodeling.","method":"Conditional PICH depletion/replacement cell lines, translocase-deficient and SIM-deficient PICH mutants, proteomics of SUMOylated chromosomal proteins, immunofluorescence for Mad1 and Bub1","journal":"Life science alliance","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional depletion with domain mutant rescue, proteomics, and IF readouts; single lab","pmids":["39919802"],"is_preprint":false},{"year":2022,"finding":"PICH regulates the expression of Nrf2 (antioxidant transcription factor) and is present on Nrf2 and antioxidant gene promoters as shown by ChIP. PICH expression is upregulated during oxidative stress and forms a regulatory loop with Nrf2. PICH depletion reduces Nrf2 expression and impairs antioxidant response, increasing ROS.","method":"ChIP on Nrf2 and antioxidant gene promoters, PICH overexpression rescue in PICH-depleted cells, ROS measurement, western blotting","journal":"Epigenomes","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, ChIP without full mechanistic dissection, single method for most claims","pmids":["36278682"],"is_preprint":false},{"year":2026,"finding":"ERCC6L stabilizes HIF-1α by inhibiting its hydroxylation and ubiquitin-mediated degradation, thereby upregulating aerobic glycolysis (Warburg effect) in lung adenocarcinoma cells. The ERCC6L/HIF-1α axis promotes cancer stemness.","method":"Overexpression/knockdown of ERCC6L, HIF-1α hydroxylation and ubiquitination assays, western blotting, in vitro and in vivo functional assays","journal":"Cell death & disease","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, mechanistic assays described briefly in abstract with limited methodological detail","pmids":["40691138"],"is_preprint":false},{"year":2026,"finding":"ERCC6L transcriptionally activates PLK1 by directly binding to its PLK1 promoter. This ERCC6L-PLK1 axis drives aerobic glycolysis, upregulating GLUT1, LDHA, PKM2, and HK2 in melanoma cells.","method":"ChIP-qPCR, dual-luciferase reporter assay, western blotting, metabolic flux analysis","journal":"Life sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, mechanistic claims resting primarily on ChIP and reporter assay without independent replication","pmids":["41564924"],"is_preprint":false},{"year":2026,"finding":"ERCC6L activates the E3 ubiquitin ligase PJA2, which mediates K48-linked polyubiquitination and proteasomal degradation of p53, attenuating its tumor-suppressive function in lung adenocarcinoma. ERCC6L knockout suppresses tumor growth and metastasis via the PJA2/p53 axis in vivo.","method":"Co-immunoprecipitation, ubiquitination assays (K48-linked), ERCC6L knockout mouse xenograft, western blotting","journal":"Respiratory research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, limited methodological detail in abstract, novel claim without independent replication","pmids":["42063149"],"is_preprint":false},{"year":2026,"finding":"PICH cooperates with the telomere-associated protein RIF1 to maintain genomic stability during iPSC reprogramming under replication stress, and overexpression of Pich improves iPSC reprogramming efficiency by alleviating replication stress.","method":"Pich knockout and overexpression in iPSC reprogramming system, RIF1 co-depletion epistasis, genomic stability assays","journal":"The FEBS journal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, novel context, limited mechanistic detail in abstract","pmids":["41981724"],"is_preprint":false}],"current_model":"PICH/ERCC6L is an SNF2-family DNA translocase and ATPase that localizes to centromeres, kinetochores, and ultrafine anaphase DNA bridges (UFBs) during mitosis, where it is recruited and regulated by Plk1 (via Cdk1-mediated phosphorylation of T1063) and by SUMO2/3 modification (which reduces its DNA binding); it directly stimulates topoisomerase IIα decatenation activity, cooperates with BLM to remodel nucleosomes and maintain histone-free UFBs, partners with TOP3α to generate positive DNA supercoiling that facilitates sister-chromatid disjunction, and—outside mitosis—participates in replication fork reversal downstream of the ZATT-TOP2A-SUMO axis and in a transcriptional complex with RNA Pol II and ATF4 to drive cyclin A1 expression."},"narrative":{"mechanistic_narrative":"ERCC6L (PICH) is an SNF2-family ATP-dependent DNA translocase that operates at centromeres, kinetochores, and ultrafine anaphase DNA bridges (UFBs) to ensure faithful sister-chromatid disjunction during mitosis [PMID:17218258, PMID:26643143]. It binds duplex DNA with an affinity that increases under tension mimicking the mitotic spindle pulling on a UFB, and uses ATP hydrolysis to translocate along and extend DNA [PMID:23973328]. Its recruitment and activity are tightly regulated: Cdk1 phosphorylates PICH at T1063 to dock Plk1 and direct PICH to inner centromeres and inter-kinetochore threads [PMID:17218258], while SUMO2/3 modification by PIASy lowers its DNA-binding capacity [PMID:25564610] and three SUMO-interacting motifs govern its centromeric versus chromatin-bridge functions [PMID:27230136]. Functionally, PICH directly stimulates topoisomerase IIα catalytic activity [PMID:26643143] and partners with TOP3α to extrude DNA loops that generate dense positive supercoiling, promoting decatenation [PMID:30936532]; in parallel it acts as a tension-dependent nucleosome remodeler that unwraps and slides histones to keep UFBs histone-free, cooperating with BLM and RIF1 in bridge resolution [PMID:21743438, PMID:36433994, PMID:39704103]. Its translocase activity also disperses SUMO2/3-modified chromosomal proteins, attenuating SUMOylated TopoIIα and modulating spindle-checkpoint signaling via Bub1 abundance [PMID:32877270, PMID:39919802]. Outside mitosis, PICH promotes extensive replication fork reversal downstream of the ZATT–TOP2A–SUMO axis [PMID:33296677]. Loss of PICH produces chromatin bridges, micronuclei, p53 activation, and chromosomal rearrangements [PMID:39704103], and in mice causes defective fetal hematopoiesis through cytoplasmic dsDNA accumulation and cGAS-STING-driven type I interferon [PMID:35037428]. ERCC6L is recurrently co-opted in cancer, where it participates in transcriptional complexes driving cyclin A1 and cell-cycle progression [PMID:37646571, PMID:37667329].","teleology":[{"year":2007,"claim":"Established PICH as a Plk1 partner whose mitotic localization is set by Cdk1 phosphorylation, defining how a DNA-acting enzyme is targeted to centromeres at the right cell-cycle moment.","evidence":"Co-IP, phosphosite mapping of T1063, siRNA and immunofluorescence in human cells","pmids":["17218258"],"confidence":"High","gaps":["Did not define the enzymatic DNA substrate","Mechanism of centromere selectivity beyond Plk1 docking unresolved"]},{"year":2007,"claim":"Showed PICH-coated inter-kinetochore threads are tension-dependent, DNase-sensitive catenated/stretched chromatin linked to topoisomerase II and cohesin, framing PICH as a marker and effector of unresolved sister-chromatid links.","evidence":"Immunofluorescence with DNase, cohesin depletion, ICRF-193 in human cells","pmids":["17218258","17956945"],"confidence":"High","gaps":["Did not establish direct biochemical action on the threads","Causality between PICH and thread resolution untested at this stage"]},{"year":2009,"claim":"Corrected the original claim of a PICH role in the spindle assembly checkpoint, attributing the apparent SAC defect to off-target siRNA suppression of Mad2 and refining PICH's function to chromosome mechanics rather than checkpoint signaling.","evidence":"siRNA specificity analysis with BAC complementation and multiple oligos","pmids":["19904549"],"confidence":"High","gaps":["Left open whether PICH influences SAC indirectly, later revisited"]},{"year":2011,"claim":"Defined PICH as a nucleosome remodeler that recruits BLM to anaphase threads, linking PICH activity to histone-free bridge resolution and prevention of centromeric micronuclei.","evidence":"PICH-BLM Co-IP, RNAi, in vitro nucleosome remodeling with purified PICH","pmids":["21743438"],"confidence":"High","gaps":["Did not resolve order of remodeling versus decatenation","BLM helicase contribution to PICH-driven resolution not separated"]},{"year":2012,"claim":"Dissected PICH ATPase requirements, showing the ATPase domain prevents chromatin bridges and controls localization while being dispensable for UFB resolution, separating its functions mechanistically.","evidence":"Antibody microinjection and ATPase-mutant siRNA rescue with quantitative bridge/UFB scoring","pmids":["22527115","22563370"],"confidence":"Medium","gaps":["Distinct molecular outputs of ATPase activity at bridges vs UFBs unclear","Single-lab phenotypic readouts"]},{"year":2013,"claim":"Reconstituted PICH biophysics, revealing tension-enhanced DNA binding, ATP-dependent translocation, DNA extension, and reduced force-induced melting—explaining how PICH preferentially acts on stretched UFB DNA.","evidence":"Optical tweezers, single-molecule fluorescence, microfluidics with purified PICH","pmids":["23973328"],"confidence":"High","gaps":["Did not connect translocation directly to decatenation in vivo","Substrate handoff to topoisomerases not addressed here"]},{"year":2015,"claim":"Demonstrated PICH directly stimulates topoisomerase II and that its ATPase activity is needed for timely UFB and rDNA resolution, providing the catalytic link between PICH and decatenation.","evidence":"PICH knockout in DT40 and human cells, ICRF-193 sensitivity, in vitro topo II activity assay","pmids":["26643143"],"confidence":"High","gaps":["Structural basis of PICH-topo II stimulation undefined","Whether stimulation occurs at all genomic loci unknown"]},{"year":2015,"claim":"Identified PICH as a SUMO2/3 substrate (via PIASy) and SUMO-binder of PARP1 and TopoIIα, with SUMOylation reducing DNA binding, establishing SUMO as a regulatory layer on PICH activity.","evidence":"Xenopus extracts, in vitro SUMOylation of recombinant PICH, Co-IP, DNA binding assay","pmids":["25564610"],"confidence":"High","gaps":["In vivo consequences of PICH SUMOylation not fully mapped","Functional SUMO sites on PICH not enumerated"]},{"year":2016,"claim":"Mapped three SUMO-interacting motifs to distinct functions—SIM3 for centromeric localization and others for bridge prevention—showing SUMO recognition partitions PICH's mitotic roles.","evidence":"Conditional expression of SIM-deficient PICH mutants with localization readouts","pmids":["27230136"],"confidence":"Medium","gaps":["SUMO partners read by each SIM not individually identified","UFB localization remained SIM-independent and unexplained"]},{"year":2017,"claim":"Solved the crystal structure of a novel PICH TPR domain–BEND3 BEN domain interface, providing the first structural account of a PICH protein interaction in mitosis.","evidence":"Co-IP, in vitro interaction, 2.2 Å crystal structure with structure-guided mutagenesis","pmids":["28977671"],"confidence":"High","gaps":["Functional role of BEND3 in PICH-dependent processes not established","How TPR-BEN binding affects translocase activity unknown"]},{"year":2019,"claim":"Reconstituted a PICH-TOP3α machine generating reverse-gyrase-like positive supercoiling through PICH loop extrusion and TOP3α relaxation, defining a topological mechanism for sister-chromatid disjunction.","evidence":"In vitro reconstitution with purified PICH and TOP3α, magnetic tweezers","pmids":["30936532"],"confidence":"High","gaps":["In vivo demonstration of supercoiling at UFBs absent","Coordination with TopoIIα decatenation not integrated"]},{"year":2020,"claim":"Placed PICH in replication stress responses, showing TOP2A-SUMO-dependent recruitment to stalled forks where it acts downstream of HLTF/ZRANB3/SMARCAL1 to enable extensive fork reversal, extending PICH function beyond mitosis.","evidence":"Knockdown epistasis, EM fork reversal assay, PLA, Co-IP","pmids":["33296677"],"confidence":"High","gaps":["Direct topological substrate at forks not visualized","Relationship to mitotic UFB function not reconciled"]},{"year":2020,"claim":"Showed PICH translocase disperses SUMO2/3 foci and attenuates SUMOylated TopoIIα, linking PICH's enzymatic activity to clearance of SUMO-modified chromosomal proteins.","evidence":"AID-based PICH depletion, translocase-mutant rescue, in vitro SUMO-TopoIIα assay, IF","pmids":["32877270"],"confidence":"High","gaps":["Full repertoire of SUMO substrates remodeled by PICH incomplete","Mechanism of SUMO-protein removal by translocation unclear"]},{"year":2022,"claim":"Visualized PICH as a tension- and ATP-dependent nucleosome remodeler that unwraps and slides histones, mechanistically explaining how UFBs become histone-free under spindle tension.","evidence":"Dual-trap optical tweezers with fluorescence imaging on nucleosome arrays","pmids":["36433994"],"confidence":"High","gaps":["Fate of displaced histones in vivo unknown","Integration with TopoIIα/TOP3α decatenation not shown"]},{"year":2022,"claim":"Linked PICH loss to organismal phenotype, showing Pich-KO causes cytoplasmic dsDNA, cGAS-STING activation, and interferon-driven loss of fetal hematopoietic stem cells, rescued by cGAS or Ifnar1 deletion.","evidence":"Pich-KO mouse, HSC transplantation, cGAS/Ifnar1 double-KO rescue, dsDNA and IFN assays","pmids":["35037428"],"confidence":"High","gaps":["Source of cytoplasmic dsDNA (unresolved bridges vs micronuclei) not pinned","Tissue specificity of the requirement unexplained"]},{"year":2023,"claim":"Defined synthetic-lethal and compensatory genetic relationships (FIRRM/FIGNL1 and RAD52) that create dependency on PICH for genome stability, identifying potential therapeutic vulnerabilities.","evidence":"Genome-wide CRISPR screens, Co-IP, UFB and RAD51/RAD52 foci, fork dynamics assays","pmids":["37347663","39561207"],"confidence":"Medium","gaps":["Direct mechanistic interaction between PICH and these pathways unresolved","Single-lab screen validations"]},{"year":2023,"claim":"Implicated ERCC6L in oncogenic cell-cycle and transcriptional programs, forming a complex with RNA Pol II and ATF4 at CCNA1 and interacting with KIF4A to drive proliferation.","evidence":"Co-IP, ChIP, ATPase-mutant, organoid/PDX and conditional-KO mouse studies","pmids":["37646571","37667329"],"confidence":"Medium","gaps":["Whether transcriptional roles are separable from translocase function unclear","Direct DNA-binding at promoters versus indirect recruitment not resolved"]},{"year":2025,"claim":"Resolved a dual role for PICH translocase in UFB resolution—generating single-stranded UFBs and stimulating TopoIIα—and tied PICH loss to DNA damage, micronuclei, p53 activation, and chromosomal rearrangements; also reconnected PICH to SAC via SUMO-protein remodeling and Bub1 control.","evidence":"Domain-mutant rescue (PICHK128A, BLM/RIF1-recruitment mutant), WGS, ssUFB IF, topo IIα assay, proteomics, Mad1/Bub1 IF","pmids":["39704103","39919802"],"confidence":"High","gaps":["Precise molecular event producing ssUFBs undefined","How SUMO-protein remodeling sets Bub1 levels mechanistically unclear"]},{"year":null,"claim":"How PICH's distinct biochemical activities—loop-extruding supercoiling with TOP3α, TopoIIα stimulation, nucleosome remodeling, and SUMO-protein dispersal—are spatially and temporally coordinated into a single coherent bridge-resolution program remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unified in vivo model linking the in vitro activities","Order and hand-off between TopoIIα, TOP3α, BLM, and RIF1 at a single UFB undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[8,10,11,15]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[10,12,13]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[7,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[11,15,17]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[20,26]}],"localization":[{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[0,1,12]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[20]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[0,1,11,24]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[16,21,23]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[16,21]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7,18]}],"complexes":[],"partners":["PLK1","BLM","TOP2A","TOP3A","RIF1","BEND3","KIF4A","ATF4"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q2NKX8","full_name":"DNA excision repair protein ERCC-6-like","aliases":["ATP-dependent helicase ERCC6-like","PLK1-interacting checkpoint helicase","Tumor antigen BJ-HCC-15"],"length_aa":1250,"mass_kda":141.1,"function":"DNA helicase that acts as a tension sensor that associates with catenated DNA which is stretched under tension until it is resolved during anaphase (PubMed:17218258, PubMed:23973328). Functions as ATP-dependent DNA translocase (PubMed:23973328, PubMed:28977671). Can promote Holliday junction branch migration (in vitro) (PubMed:23973328)","subcellular_location":"Chromosome, centromere; Chromosome, centromere, kinetochore; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q2NKX8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ERCC6L","classification":"Not Classified","n_dependent_lines":157,"n_total_lines":1208,"dependency_fraction":0.12996688741721854},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"BRD2","stoichiometry":0.2},{"gene":"MINK1","stoichiometry":0.2},{"gene":"PASK","stoichiometry":0.2},{"gene":"PLK1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ERCC6L","total_profiled":1310},"omim":[{"mim_id":"621430","title":"FIGNL1-INTERACTING REGULATOR OF RECOMBINATION AND MITOSIS; FIRRM","url":"https://www.omim.org/entry/621430"},{"mim_id":"616374","title":"BEN DOMAIN-CONTAINING PROTEIN 3; BEND3","url":"https://www.omim.org/entry/616374"},{"mim_id":"615383","title":"FIDGETIN-LIKE PROTEIN 1; FIGNL1","url":"https://www.omim.org/entry/615383"},{"mim_id":"300687","title":"ERCC EXCISION REPAIR 6-LIKE, SPINDLE ASSEMBLY CHECKPOINT HELICASE; ERCC6L","url":"https://www.omim.org/entry/300687"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Centrosome","reliability":"Uncertain"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":3.0},{"tissue":"lymphoid tissue","ntpm":3.3}],"url":"https://www.proteinatlas.org/search/ERCC6L"},"hgnc":{"alias_symbol":["FLJ20105","PICH","RAD26L"],"prev_symbol":[]},"alphafold":{"accession":"Q2NKX8","domains":[{"cath_id":"-","chopping":"2-74","consensus_level":"medium","plddt":74.9292,"start":2,"end":74},{"cath_id":"3.40.50.10810","chopping":"79-276_327-337","consensus_level":"high","plddt":87.3169,"start":79,"end":337},{"cath_id":"-","chopping":"375-427","consensus_level":"medium","plddt":75.1266,"start":375,"end":427},{"cath_id":"3.40.50.300","chopping":"453-585","consensus_level":"medium","plddt":88.0255,"start":453,"end":585},{"cath_id":"1.10.10","chopping":"1201-1250","consensus_level":"medium","plddt":87.939,"start":1201,"end":1250}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q2NKX8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q2NKX8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q2NKX8-F1-predicted_aligned_error_v6.png","plddt_mean":62.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ERCC6L","jax_strain_url":"https://www.jax.org/strain/search?query=ERCC6L"},"sequence":{"accession":"Q2NKX8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q2NKX8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q2NKX8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q2NKX8"}},"corpus_meta":[{"pmid":"17218258","id":"PMC_17218258","title":"PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17218258","citation_count":287,"is_preprint":false},{"pmid":"26643143","id":"PMC_26643143","title":"PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26643143","citation_count":98,"is_preprint":false},{"pmid":"23973328","id":"PMC_23973328","title":"PICH: a DNA translocase specially adapted for processing anaphase bridge DNA.","date":"2013","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/23973328","citation_count":88,"is_preprint":false},{"pmid":"21743438","id":"PMC_21743438","title":"PICH and BLM limit histone association with anaphase centromeric DNA threads and promote their resolution.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21743438","citation_count":79,"is_preprint":false},{"pmid":"33296677","id":"PMC_33296677","title":"The ZATT-TOP2A-PICH Axis Drives Extensive Replication Fork Reversal to Promote Genome Stability.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33296677","citation_count":67,"is_preprint":false},{"pmid":"17956945","id":"PMC_17956945","title":"Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads.","date":"2007","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17956945","citation_count":67,"is_preprint":false},{"pmid":"19904549","id":"PMC_19904549","title":"Re-examination of siRNA specificity questions role of PICH and Tao1 in the spindle checkpoint and identifies Mad2 as a sensitive target for small RNAs.","date":"2009","source":"Chromosoma","url":"https://pubmed.ncbi.nlm.nih.gov/19904549","citation_count":57,"is_preprint":false},{"pmid":"11579222","id":"PMC_11579222","title":"Stabilization of local structures by pi-CH and aromatic-backbone amide interactions involving prolyl and aromatic residues.","date":"2001","source":"Protein engineering","url":"https://pubmed.ncbi.nlm.nih.gov/11579222","citation_count":51,"is_preprint":false},{"pmid":"22563370","id":"PMC_22563370","title":"Bloom's syndrome and PICH helicases cooperate with topoisomerase IIα in centromere disjunction before anaphase.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22563370","citation_count":50,"is_preprint":false},{"pmid":"20130082","id":"PMC_20130082","title":"PICH and cotargeted Plk1 coordinately maintain prometaphase chromosome arm architecture.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20130082","citation_count":37,"is_preprint":false},{"pmid":"30936532","id":"PMC_30936532","title":"PICH and TOP3A cooperate to induce positive DNA supercoiling.","date":"2019","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30936532","citation_count":37,"is_preprint":false},{"pmid":"28178669","id":"PMC_28178669","title":"ERCC6L, a DNA helicase, is involved in cell proliferation and associated with survival and progress in breast and kidney cancers.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28178669","citation_count":35,"is_preprint":false},{"pmid":"22527115","id":"PMC_22527115","title":"On the regulation, function, and localization of the DNA-dependent ATPase PICH.","date":"2012","source":"Chromosoma","url":"https://pubmed.ncbi.nlm.nih.gov/22527115","citation_count":35,"is_preprint":false},{"pmid":"18418076","id":"PMC_18418076","title":"Targeting Plk1 to chromosome arms and regulating chromosome compaction by the PICH ATPase.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18418076","citation_count":31,"is_preprint":false},{"pmid":"30232008","id":"PMC_30232008","title":"Loss of PICH Results in Chromosomal Instability, p53 Activation, and Embryonic Lethality.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30232008","citation_count":30,"is_preprint":false},{"pmid":"27565185","id":"PMC_27565185","title":"PICH promotes mitotic chromosome segregation: Identification of a novel role in rDNA disjunction.","date":"2016","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/27565185","citation_count":30,"is_preprint":false},{"pmid":"31160555","id":"PMC_31160555","title":"Loss of PICH promotes chromosome instability and cell death in triple-negative breast cancer.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31160555","citation_count":29,"is_preprint":false},{"pmid":"25564610","id":"PMC_25564610","title":"SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25564610","citation_count":25,"is_preprint":false},{"pmid":"37347663","id":"PMC_37347663","title":"FIRRM/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37347663","citation_count":24,"is_preprint":false},{"pmid":"30459398","id":"PMC_30459398","title":"ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.","date":"2018","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30459398","citation_count":24,"is_preprint":false},{"pmid":"31289493","id":"PMC_31289493","title":"ERCC6L promotes cell growth and invasion in human colorectal cancer.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31289493","citation_count":21,"is_preprint":false},{"pmid":"32891122","id":"PMC_32891122","title":"ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.","date":"2020","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32891122","citation_count":20,"is_preprint":false},{"pmid":"27230136","id":"PMC_27230136","title":"SUMO-interacting motifs (SIMs) in Polo-like kinase 1-interacting checkpoint helicase (PICH) ensure proper chromosome segregation during mitosis.","date":"2016","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/27230136","citation_count":20,"is_preprint":false},{"pmid":"30066865","id":"PMC_30066865","title":"shRNA knockdown of DNA helicase ERCC6L expression inhibits human breast cancer growth.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30066865","citation_count":17,"is_preprint":false},{"pmid":"15917148","id":"PMC_15917148","title":"Ercc6l, a gene of SNF2 family, may play a role in the teratogenic action of alcohol.","date":"2005","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/15917148","citation_count":17,"is_preprint":false},{"pmid":"35037428","id":"PMC_35037428","title":"PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS-STING-Mediated Interferon Response.","date":"2022","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/35037428","citation_count":16,"is_preprint":false},{"pmid":"37667329","id":"PMC_37667329","title":"ERCC6L facilitates the onset of mammary neoplasia and promotes the high malignance of breast cancer by accelerating the cell cycle.","date":"2023","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/37667329","citation_count":15,"is_preprint":false},{"pmid":"36433994","id":"PMC_36433994","title":"PICH acts as a force-dependent nucleosome remodeler.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36433994","citation_count":14,"is_preprint":false},{"pmid":"37646571","id":"PMC_37646571","title":"PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric Cancer.","date":"2023","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/37646571","citation_count":14,"is_preprint":false},{"pmid":"28977671","id":"PMC_28977671","title":"A novel TPR-BEN domain interaction mediates PICH-BEND3 association.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28977671","citation_count":14,"is_preprint":false},{"pmid":"32877270","id":"PMC_32877270","title":"PICH regulates the abundance and localization of SUMOylated proteins on mitotic chromosomes.","date":"2020","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/32877270","citation_count":13,"is_preprint":false},{"pmid":"32347436","id":"PMC_32347436","title":"Upregulation of Excision Repair Cross-Complementation Group 6-Like (ERCC6L) Promotes Tumor Growth in Hepatocellular Carcinoma.","date":"2020","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32347436","citation_count":11,"is_preprint":false},{"pmid":"34425559","id":"PMC_34425559","title":"ERCC6L promotes cell growth and metastasis in gastric cancer through activating NF-κB signaling.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/34425559","citation_count":9,"is_preprint":false},{"pmid":"36550435","id":"PMC_36550435","title":"A pan-cancer analysis of the oncogenic role of ERCC6L.","date":"2022","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36550435","citation_count":9,"is_preprint":false},{"pmid":"35150321","id":"PMC_35150321","title":"ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.","date":"2022","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35150321","citation_count":8,"is_preprint":false},{"pmid":"34530686","id":"PMC_34530686","title":"Regulation of mitotic chromosome architecture and resolution of ultrafine anaphase bridges by PICH.","date":"2021","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/34530686","citation_count":8,"is_preprint":false},{"pmid":"36726012","id":"PMC_36726012","title":"ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and KIF4A.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/36726012","citation_count":5,"is_preprint":false},{"pmid":"27487930","id":"PMC_27487930","title":"Characterization of the NTPR and BD1 interacting domains of the human PICH-BEND3 complex.","date":"2016","source":"Acta crystallographica. Section F, Structural biology communications","url":"https://pubmed.ncbi.nlm.nih.gov/27487930","citation_count":5,"is_preprint":false},{"pmid":"27142171","id":"PMC_27142171","title":"Isolation and Proteomics Analysis of Barley Centromeric Chromatin Using PICh.","date":"2016","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/27142171","citation_count":5,"is_preprint":false},{"pmid":"37854939","id":"PMC_37854939","title":"Pan-genomic comparison of a potential solvent-tolerant alkaline protease-producing Exiguobacterium sp. TBG-PICH-001 isolated from a marine habitat.","date":"2023","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/37854939","citation_count":5,"is_preprint":false},{"pmid":"38253636","id":"PMC_38253636","title":"PICH deficiency limits the progression of MYC-induced B-cell lymphoma.","date":"2024","source":"Blood cancer journal","url":"https://pubmed.ncbi.nlm.nih.gov/38253636","citation_count":4,"is_preprint":false},{"pmid":"17218250","id":"PMC_17218250","title":"Polo delivers a PICH to the kinetochore.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17218250","citation_count":4,"is_preprint":false},{"pmid":"40691138","id":"PMC_40691138","title":"ERCC6L-mediated stabilization of HIF-1α enhances glycolysis and stemness properties of lung adenocarcinoma cells.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/40691138","citation_count":3,"is_preprint":false},{"pmid":"39503234","id":"PMC_39503234","title":"Anti-Proliferation Effect of Nodosin on Hepatocellular Carcinoma Cells Via The ERCC6L/PI3K/AKT/Axis.","date":"2024","source":"Journal of biochemical and molecular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/39503234","citation_count":2,"is_preprint":false},{"pmid":"39561207","id":"PMC_39561207","title":"RAD52 and ERCC6L/PICH have a compensatory relationship for genome stability in mitosis.","date":"2024","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39561207","citation_count":1,"is_preprint":false},{"pmid":"39491600","id":"PMC_39491600","title":"PICH, A protein that maintains genomic stability, can promote tumor growth.","date":"2024","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/39491600","citation_count":1,"is_preprint":false},{"pmid":"39704103","id":"PMC_39704103","title":"The interplay of the translocase activity and protein recruitment function of PICH in ultrafine anaphase bridge resolution and genomic stability.","date":"2025","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/39704103","citation_count":1,"is_preprint":false},{"pmid":"39919802","id":"PMC_39919802","title":"PICH impacts the spindle assembly checkpoint via its DNA translocase and SUMO-interaction activities.","date":"2025","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/39919802","citation_count":0,"is_preprint":false},{"pmid":"37662271","id":"PMC_37662271","title":"RAD52 and ERCC6L/PICH have a compensatory relationship for genome stability in mitosis.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37662271","citation_count":0,"is_preprint":false},{"pmid":"36278682","id":"PMC_36278682","title":"PLK-1 Interacting Checkpoint Helicase, PICH, Mediates Cellular Oxidative Stress Response.","date":"2022","source":"Epigenomes","url":"https://pubmed.ncbi.nlm.nih.gov/36278682","citation_count":0,"is_preprint":false},{"pmid":"42063149","id":"PMC_42063149","title":"ERCC6L drives lung adenocarcinoma metastasis: a PJA2/p53 ubiquitination-dependent mechanism.","date":"2026","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/42063149","citation_count":0,"is_preprint":false},{"pmid":"41564924","id":"PMC_41564924","title":"ERCC6L promotes cutaneous melanoma progression via PLK1-mediated aerobic glycolysis: Mechanisms and therapeutic implications.","date":"2026","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41564924","citation_count":0,"is_preprint":false},{"pmid":"41981724","id":"PMC_41981724","title":"PICH facilitates iPSC reprogramming by alleviating genomic instability induced by DNA replication stress.","date":"2026","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/41981724","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.16.659902","title":"Mitotic BLM functions are required to maintain genomic stability","date":"2025-06-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.16.659902","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25767,"output_tokens":7481,"usd":0.094758,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16819,"output_tokens":5633,"usd":0.11246,"stage2_stop_reason":"end_turn"},"total_usd":0.207218,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"PICH is an interaction partner and substrate of Plk1; Cdk1 phosphorylates PICH on T1063, which recruits Plk1 to PICH and controls its localization to kinetochores, inner centromeres, and inter-kinetochore threads during mitosis.\",\n      \"method\": \"Co-immunoprecipitation, phosphorylation mapping, siRNA knockdown, immunofluorescence\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP with phosphorylation site identification, replicated across multiple orthogonal methods in the foundational paper, widely cited and built upon\",\n      \"pmids\": [\"17218258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PICH-positive inter-kinetochore threads are tension-dependent, DNase-sensitive, and exacerbated by premature cohesin loss or topoisomerase II inhibition, suggesting they represent stretched centromeric chromatin/catenated DNA.\",\n      \"method\": \"Immunofluorescence, DNase treatment, siRNA knockdown of cohesins, topoisomerase II inhibitor (ICRF-193) treatment\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal perturbations (DNase, cohesin depletion, topo II inhibition) in a single rigorous study, widely replicated conceptually\",\n      \"pmids\": [\"17218258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Depletion of PICH causes selective loss of Mad2 from kinetochores and abrogates the spindle checkpoint; however, subsequent work showed this effect was due to off-target siRNA suppression of Mad2, not a direct PICH function in the SAC.\",\n      \"method\": \"siRNA knockdown, immunofluorescence for Mad2, rescue with Mad2-expressing BAC, multiple siRNA oligonucleotides\",\n      \"journal\": \"Cell / Chromosoma\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — original claim (PMID 17218258) refuted by rigorous siRNA specificity analysis (PMID 19904549) using BAC rescue and multiple oligos; negative/retracted finding recorded explicitly\",\n      \"pmids\": [\"17218258\", \"19904549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PICH does not have a direct role in spindle assembly checkpoint (SAC) signaling; siRNAs targeting PICH that abolished the SAC also reduced Mad2 mRNA/protein as an off-target effect. siRNAs that effectively deplete PICH without affecting Mad2 do not abolish SAC functionality.\",\n      \"method\": \"siRNA specificity analysis, BAC complementation expressing murine Mad2, Plk1 depletion/inhibition rescue experiments\",\n      \"journal\": \"Chromosoma\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous siRNA specificity controls with BAC rescue, multiple orthogonal approaches disproving original claim\",\n      \"pmids\": [\"19904549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Depletion of topoisomerase IIα leads to abnormal persistence of PICH-coated anaphase threads connecting segregating chromatids and shortening of the metaphase inter-kinetochore distance, indicating functional cooperation between PICH and topo IIα at centromeres.\",\n      \"method\": \"Conditional-lethal topo IIα mutant cell line, immunofluorescence for PICH, FISH\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, clean genetic system but single method readout for PICH phenotype\",\n      \"pmids\": [\"17956945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PICH recruits Plk1 to chromosome arms during mitosis; disruption of the PICH-Plk1 interaction abolishes Plk1 localization on chromosome arms. Both PICH phosphorylation and its ATPase activity are required for mitotic chromosome compaction.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative PICH mutants (Plk1-binding deficient, ATP-binding deficient), immunofluorescence\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus multiple domain mutants in one lab; two orthogonal methods\",\n      \"pmids\": [\"18418076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PICH and Plk1 coordinately maintain prometaphase chromosome arm architecture; PICH knockdown causes loss of Plk1 from chromosome arms and produces disorganized 'wavy' chromosomes with an open/X-shaped configuration that is prevented by topoisomerase II inhibitor ICRF-193, indicating the PICH-Plk1 complex maintains chromosome architecture in a topo II-dependent manner.\",\n      \"method\": \"siRNA knockdown, immunofluorescence for Plk1/condensin/cohesin, ICRF-193 treatment\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi phenotype with pharmacological rescue and multiple localization markers, single lab\",\n      \"pmids\": [\"20130082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PICH directly binds BLM and enables BLM localization to anaphase centromeric threads. Purified recombinant PICH has nucleosome remodeling activity in vitro. PICH- or BLM-depleted cells fail to resolve anaphase threads, which then contain histones and centromere markers, forming centromeric micronuclei.\",\n      \"method\": \"Co-immunoprecipitation (PICH-BLM), RNAi knockdown, in vitro nucleosome remodeling assay with purified recombinant PICH, immunofluorescence\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro nucleosome remodeling with purified protein plus reciprocal Co-IP and RNAi phenotype, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"21743438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ATPase activity of PICH is critical for its function: an intact ATPase domain is required to prevent chromatin bridge formation but is not required for UFB resolution. ATPase activity is also required for temporal and spatial control of PICH localization to chromatin.\",\n      \"method\": \"Antibody microinjection, siRNA rescue with ATPase-mutant PICH, quantitative analysis of UFB and chromatin bridge frequencies\",\n      \"journal\": \"Chromosoma\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mutagenesis combined with rescue experiments and quantitative phenotypic readouts, single lab\",\n      \"pmids\": [\"22527115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BLM and PICH cooperate to recruit active topoisomerase IIα to centromeres; both BLM-deficient and PICH-deficient prometaphase cells display centromere structural changes, higher centromeric non-disjunction in cohesin-free conditions, and defective topoisomerase IIα centromere recruitment.\",\n      \"method\": \"RNAi knockdown, immunofluorescence, chromatin immunoprecipitation, electron microscopy, FISH\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (ChIP, EM, FISH, IF) in single lab\",\n      \"pmids\": [\"22563370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PICH binds duplex DNA with remarkably high affinity, and this affinity increases with tension-induced DNA stretching, mimicking the mitotic spindle on a UFB. PICH performs ATP-dependent protein translocation and extends DNA. PICH binding diminishes force-induced DNA melting.\",\n      \"method\": \"Microfluidics, single-molecule fluorescence microscopy, optical tweezers, in vitro assays with purified PICH\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro with purified protein using multiple biophysical methods (optical tweezers, single-molecule fluorescence, microfluidics) in a single rigorous study\",\n      \"pmids\": [\"23973328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PICH directly stimulates the catalytic activity of topoisomerase II in vitro. Deletion of PICH causes chromosome structural abnormalities, hypersensitivity to topo II inhibitor ICRF-193, sister chromatid non-disjunction in anaphase, and cytokinesis failure. The timely resolution of UFBs and rDNA structures depends on the ATPase activity of PICH.\",\n      \"method\": \"PICH knockout in avian (DT40) cells and human cell line, ICRF-193 sensitivity assay, in vitro topo II activity assay with purified PICH protein\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution with purified proteins plus genetic knockout in two different cell systems with defined phenotypic readouts\",\n      \"pmids\": [\"26643143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PICH is modified by SUMO2/3 on mitotic chromosomes and in vitro, mediated by the SUMO E3 ligase PIASy. PICH interacts with SUMOylated PARP1 and SUMOylated topoisomerase IIα. SUMOylation of PICH significantly reduces its DNA binding capability, suggesting SUMO regulates PICH ATPase activity.\",\n      \"method\": \"Xenopus egg extract assays, co-immunoprecipitation with SUMOylated substrates, in vitro SUMOylation assay with purified recombinant human PICH, DNA binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro biochemical assays with purified recombinant PICH plus Xenopus extract experiments and DNA binding functional readout, multiple orthogonal methods\",\n      \"pmids\": [\"25564610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PICH contains three SUMO-interacting motifs (SIMs). SIM3 (near the C-terminus) is critical for PICH centromeric localization, while the other two SIMs function in chromatin bridge prevention. All SIMs are dispensable for PICH localization to ultrafine anaphase DNA bridges.\",\n      \"method\": \"Conditional PICH expression, SIM-deficient PICH mutants, immunofluorescence\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mutagenesis (three SIM mutations) with rescue and localization readouts, single lab\",\n      \"pmids\": [\"27230136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PICH interacts with the BEN domain-containing protein BEND3 in human cells during mitosis via a novel TPR domain (in PICH) – BEN domain (in BEND3) interface. The crystal structure of the TPR-BEN complex was determined at 2.2 Å resolution, and structure-guided mutagenesis identified residues critical for the interaction.\",\n      \"method\": \"Co-immunoprecipitation in human cells, purification of full-length proteins, in vitro biochemical interaction assay, crystal structure at 2.2 Å (MAD phasing), structure-guided mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation by mutagenesis and biochemical interaction assays, multiple orthogonal methods in one study\",\n      \"pmids\": [\"28977671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PICH and Topoisomerase 3α (TOP3A) together create an extraordinarily high density of positive DNA supercoiling, analogous to a reverse-gyrase activity, driven by PICH progressively extruding hypernegatively supercoiled DNA loops that are relaxed by TOP3A.\",\n      \"method\": \"In vitro reconstitution with purified human PICH and TOP3α, magnetic tweezers single-molecule assay\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of a novel enzymatic activity with purified proteins and single-molecule biophysics\",\n      \"pmids\": [\"30936532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Upon replication stress, PICH is recruited to stalled replication forks in a manner dependent on TOP2A SUMOylation by ZATT. PICH acts downstream of HLTF/ZRANB3/SMARCAL1 (which initiate limited fork reversal) to promote extensive fork reversal by resolving topological barriers. Disruption of the ZATT-TOP2A-PICH axis results in accumulation of partially reversed forks and enhanced genome instability.\",\n      \"method\": \"siRNA/shRNA knockdown of pathway components, replication fork reversal assay (electron microscopy), proximity ligation assay, co-immunoprecipitation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis mapping with multiple knockdowns and EM-based fork reversal assay, plus Co-IP, multiple orthogonal methods\",\n      \"pmids\": [\"33296677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PICH specifically disperses SUMO2/3 foci on mitotic chromosomes; this requires its DNA translocase activity. PICH uses its SUMO-binding ability to attenuate SUMOylated TopoIIα activity in vitro. Conditional depletion of PICH causes retention of SUMO2/3-modified chromosomal proteins including TopoIIα.\",\n      \"method\": \"Auxin-inducible degron (AID) PICH depletion, translocase-deficient PICH mutant rescue, in vitro TopoIIα activity assay with SUMOylated substrate, immunofluorescence\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro enzymatic assay plus AID depletion system with domain mutant rescue, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"32877270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PICH is a tension- and ATP-dependent nucleosome remodeler: under tension mimicking anaphase chromatin bridges, PICH facilitates nucleosome unwrapping and subsequently slides remaining histones along the DNA.\",\n      \"method\": \"Single-molecule assay: dual-trap optical tweezers combined with fluorescence imaging of PICH and histones on nucleosome-array constructs in vitro\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified proteins, single-molecule biophysics with direct visualization of nucleosome remodeling events\",\n      \"pmids\": [\"36433994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PICH deficiency in mice leads to defective embryonic hematopoiesis: Pich-KO fetal liver HSCs show elevated cytoplasmic dsDNA and activation of the cGAS-STING pathway, resulting in excessive type I interferon production and apoptosis. Deletion of Ifnar1 or cGAS reverses the defective hematopoiesis.\",\n      \"method\": \"Pich knockout mouse model, HSC transplantation assay, cGAS/Ifnar1 double knockout rescue, cytoplasmic dsDNA staining, interferon quantification\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis using double KO rescue (cGAS-KO and Ifnar1-KO), transplantation functional readout, multiple orthogonal approaches\",\n      \"pmids\": [\"35037428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PICH forms a transcriptional complex with RNA polymerase II and ATF4 at the CCNA1 (cyclin A1) promoter in an ATPase-dependent manner, promoting cyclin A1 transcription and accelerating S-phase progression, thereby impairing 5-FU chemosensitivity in gastric cancer.\",\n      \"method\": \"Co-immunoprecipitation (PICH-PolII-ATF4), ChIP at CCNA1 promoter, ATPase-deficient PICH mutant, organoid and patient-derived xenograft assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, ChIP, domain mutant, and in vivo PDX validation in single lab; multiple methods\",\n      \"pmids\": [\"37646571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FIRRM (C1orf112) and FIGNL1 inactivation creates synthetic lethality with PICH (ERCC6L). FIRRM interacts with and stabilizes FIGNL1; loss of either leads to UFB formation, prolonged RAD51 foci, and impaired replication fork dynamics, creating dependency on PICH for viability.\",\n      \"method\": \"Genome-wide CRISPR knockout screen, co-immunoprecipitation (FIRRM-FIGNL1), UFB imaging, RAD51 foci quantification, replication fork dynamics assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide screen plus co-IP and multiple functional readouts, single lab\",\n      \"pmids\": [\"37347663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ERCC6L directly interacts with KIF4A; both proteins cooperate in mitosis and breast cancer cell progression. ERCC6L accelerates the cell cycle by regulating the G2/M checkpoint via p53/p21/CDK1/Cyclin B and PLK/CDC25C/CDK1/Cyclin B signaling pathways.\",\n      \"method\": \"Co-immunoprecipitation (ERCC6L-KIF4A), ERCC6L conditional knockout mouse model, western blotting of pathway components, cell cycle analysis\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for interaction plus conditional KO mouse and pathway western blots, single lab\",\n      \"pmids\": [\"37667329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RAD52 deficiency increases ERCC6L-coated anaphase UFBs, and ERCC6L depletion causes elevated RAD52 foci in prometaphase and interphase cells. RAD52 and ERCC6L have a compensatory/synthetic-lethal relationship for genome stability in mitosis, enhanced by replication stress and topo IIα inhibition.\",\n      \"method\": \"Genome-wide CRISPR knockout screen, RAD52-deficient cell lines, ERCC6L depletion, UFB quantification, 53BP1 foci quantification, hydroxyurea and ICRF-193 treatment\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide screen followed by secondary validation with multiple perturbations and readouts, single lab\",\n      \"pmids\": [\"39561207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PICH's translocase activity plays a dual role in UFB resolution: facilitating generation of single-stranded UFBs and stimulating topoisomerase IIα. A PICH mutant impairing UFB recruitment of BLM and RIF1 partially inhibits UFB resolution, while a translocase-inactive mutant (PICHK128A) completely fails to resolve UFBs and also inhibits single-stranded UFB formation and induces hypocondensed chromosomes. PICH depletion in diploid cells induces DNA damage, micronuclei, p53 activation, G1-phase delay, and chromosomal rearrangements (translocations and inversions) detected by whole-genome sequencing.\",\n      \"method\": \"PICH depletion, domain mutant rescue (translocase-inactive PICHK128A, BLM/RIF1 recruitment mutant), whole-genome sequencing, single-stranded UFB immunofluorescence, topo IIα stimulation assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple domain mutants with functional rescue, WGS genomic readout, and biochemical topo IIα assay; multiple orthogonal approaches in single study\",\n      \"pmids\": [\"39704103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PICH impacts spindle assembly checkpoint (SAC) activity via both its DNA translocase activity and SUMO-interaction (SIM) activities. Defects in either PICH remodeling or SIM function delay mitotic progression by activating the SAC (extended Mad1 foci at centromeres). PICH controls Bub1 kinetochore abundance, and loss of PICH leads to increased Bub1 at kinetochores, implicating PICH in SAC regulation through SUMOylated chromosomal protein remodeling.\",\n      \"method\": \"Conditional PICH depletion/replacement cell lines, translocase-deficient and SIM-deficient PICH mutants, proteomics of SUMOylated chromosomal proteins, immunofluorescence for Mad1 and Bub1\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional depletion with domain mutant rescue, proteomics, and IF readouts; single lab\",\n      \"pmids\": [\"39919802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PICH regulates the expression of Nrf2 (antioxidant transcription factor) and is present on Nrf2 and antioxidant gene promoters as shown by ChIP. PICH expression is upregulated during oxidative stress and forms a regulatory loop with Nrf2. PICH depletion reduces Nrf2 expression and impairs antioxidant response, increasing ROS.\",\n      \"method\": \"ChIP on Nrf2 and antioxidant gene promoters, PICH overexpression rescue in PICH-depleted cells, ROS measurement, western blotting\",\n      \"journal\": \"Epigenomes\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, ChIP without full mechanistic dissection, single method for most claims\",\n      \"pmids\": [\"36278682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"ERCC6L stabilizes HIF-1α by inhibiting its hydroxylation and ubiquitin-mediated degradation, thereby upregulating aerobic glycolysis (Warburg effect) in lung adenocarcinoma cells. The ERCC6L/HIF-1α axis promotes cancer stemness.\",\n      \"method\": \"Overexpression/knockdown of ERCC6L, HIF-1α hydroxylation and ubiquitination assays, western blotting, in vitro and in vivo functional assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, mechanistic assays described briefly in abstract with limited methodological detail\",\n      \"pmids\": [\"40691138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"ERCC6L transcriptionally activates PLK1 by directly binding to its PLK1 promoter. This ERCC6L-PLK1 axis drives aerobic glycolysis, upregulating GLUT1, LDHA, PKM2, and HK2 in melanoma cells.\",\n      \"method\": \"ChIP-qPCR, dual-luciferase reporter assay, western blotting, metabolic flux analysis\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, mechanistic claims resting primarily on ChIP and reporter assay without independent replication\",\n      \"pmids\": [\"41564924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"ERCC6L activates the E3 ubiquitin ligase PJA2, which mediates K48-linked polyubiquitination and proteasomal degradation of p53, attenuating its tumor-suppressive function in lung adenocarcinoma. ERCC6L knockout suppresses tumor growth and metastasis via the PJA2/p53 axis in vivo.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays (K48-linked), ERCC6L knockout mouse xenograft, western blotting\",\n      \"journal\": \"Respiratory research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, limited methodological detail in abstract, novel claim without independent replication\",\n      \"pmids\": [\"42063149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"PICH cooperates with the telomere-associated protein RIF1 to maintain genomic stability during iPSC reprogramming under replication stress, and overexpression of Pich improves iPSC reprogramming efficiency by alleviating replication stress.\",\n      \"method\": \"Pich knockout and overexpression in iPSC reprogramming system, RIF1 co-depletion epistasis, genomic stability assays\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, novel context, limited mechanistic detail in abstract\",\n      \"pmids\": [\"41981724\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PICH/ERCC6L is an SNF2-family DNA translocase and ATPase that localizes to centromeres, kinetochores, and ultrafine anaphase DNA bridges (UFBs) during mitosis, where it is recruited and regulated by Plk1 (via Cdk1-mediated phosphorylation of T1063) and by SUMO2/3 modification (which reduces its DNA binding); it directly stimulates topoisomerase IIα decatenation activity, cooperates with BLM to remodel nucleosomes and maintain histone-free UFBs, partners with TOP3α to generate positive DNA supercoiling that facilitates sister-chromatid disjunction, and—outside mitosis—participates in replication fork reversal downstream of the ZATT-TOP2A-SUMO axis and in a transcriptional complex with RNA Pol II and ATF4 to drive cyclin A1 expression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ERCC6L (PICH) is an SNF2-family ATP-dependent DNA translocase that operates at centromeres, kinetochores, and ultrafine anaphase DNA bridges (UFBs) to ensure faithful sister-chromatid disjunction during mitosis [#0, #1, #11]. It binds duplex DNA with an affinity that increases under tension mimicking the mitotic spindle pulling on a UFB, and uses ATP hydrolysis to translocate along and extend DNA [#10]. Its recruitment and activity are tightly regulated: Cdk1 phosphorylates PICH at T1063 to dock Plk1 and direct PICH to inner centromeres and inter-kinetochore threads [#0], while SUMO2/3 modification by PIASy lowers its DNA-binding capacity [#12] and three SUMO-interacting motifs govern its centromeric versus chromatin-bridge functions [#13]. Functionally, PICH directly stimulates topoisomerase IIα catalytic activity [#11] and partners with TOP3α to extrude DNA loops that generate dense positive supercoiling, promoting decatenation [#15]; in parallel it acts as a tension-dependent nucleosome remodeler that unwraps and slides histones to keep UFBs histone-free, cooperating with BLM and RIF1 in bridge resolution [#7, #18, #24]. Its translocase activity also disperses SUMO2/3-modified chromosomal proteins, attenuating SUMOylated TopoIIα and modulating spindle-checkpoint signaling via Bub1 abundance [#17, #25]. Outside mitosis, PICH promotes extensive replication fork reversal downstream of the ZATT–TOP2A–SUMO axis [#16]. Loss of PICH produces chromatin bridges, micronuclei, p53 activation, and chromosomal rearrangements [#24], and in mice causes defective fetal hematopoiesis through cytoplasmic dsDNA accumulation and cGAS-STING-driven type I interferon [#19]. ERCC6L is recurrently co-opted in cancer, where it participates in transcriptional complexes driving cyclin A1 and cell-cycle progression [#20, #22].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Established PICH as a Plk1 partner whose mitotic localization is set by Cdk1 phosphorylation, defining how a DNA-acting enzyme is targeted to centromeres at the right cell-cycle moment.\",\n      \"evidence\": \"Co-IP, phosphosite mapping of T1063, siRNA and immunofluorescence in human cells\",\n      \"pmids\": [\"17218258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the enzymatic DNA substrate\", \"Mechanism of centromere selectivity beyond Plk1 docking unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed PICH-coated inter-kinetochore threads are tension-dependent, DNase-sensitive catenated/stretched chromatin linked to topoisomerase II and cohesin, framing PICH as a marker and effector of unresolved sister-chromatid links.\",\n      \"evidence\": \"Immunofluorescence with DNase, cohesin depletion, ICRF-193 in human cells\",\n      \"pmids\": [\"17218258\", \"17956945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish direct biochemical action on the threads\", \"Causality between PICH and thread resolution untested at this stage\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Corrected the original claim of a PICH role in the spindle assembly checkpoint, attributing the apparent SAC defect to off-target siRNA suppression of Mad2 and refining PICH's function to chromosome mechanics rather than checkpoint signaling.\",\n      \"evidence\": \"siRNA specificity analysis with BAC complementation and multiple oligos\",\n      \"pmids\": [\"19904549\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Left open whether PICH influences SAC indirectly, later revisited\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined PICH as a nucleosome remodeler that recruits BLM to anaphase threads, linking PICH activity to histone-free bridge resolution and prevention of centromeric micronuclei.\",\n      \"evidence\": \"PICH-BLM Co-IP, RNAi, in vitro nucleosome remodeling with purified PICH\",\n      \"pmids\": [\"21743438\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve order of remodeling versus decatenation\", \"BLM helicase contribution to PICH-driven resolution not separated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Dissected PICH ATPase requirements, showing the ATPase domain prevents chromatin bridges and controls localization while being dispensable for UFB resolution, separating its functions mechanistically.\",\n      \"evidence\": \"Antibody microinjection and ATPase-mutant siRNA rescue with quantitative bridge/UFB scoring\",\n      \"pmids\": [\"22527115\", \"22563370\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Distinct molecular outputs of ATPase activity at bridges vs UFBs unclear\", \"Single-lab phenotypic readouts\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Reconstituted PICH biophysics, revealing tension-enhanced DNA binding, ATP-dependent translocation, DNA extension, and reduced force-induced melting—explaining how PICH preferentially acts on stretched UFB DNA.\",\n      \"evidence\": \"Optical tweezers, single-molecule fluorescence, microfluidics with purified PICH\",\n      \"pmids\": [\"23973328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not connect translocation directly to decatenation in vivo\", \"Substrate handoff to topoisomerases not addressed here\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated PICH directly stimulates topoisomerase II and that its ATPase activity is needed for timely UFB and rDNA resolution, providing the catalytic link between PICH and decatenation.\",\n      \"evidence\": \"PICH knockout in DT40 and human cells, ICRF-193 sensitivity, in vitro topo II activity assay\",\n      \"pmids\": [\"26643143\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of PICH-topo II stimulation undefined\", \"Whether stimulation occurs at all genomic loci unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified PICH as a SUMO2/3 substrate (via PIASy) and SUMO-binder of PARP1 and TopoIIα, with SUMOylation reducing DNA binding, establishing SUMO as a regulatory layer on PICH activity.\",\n      \"evidence\": \"Xenopus extracts, in vitro SUMOylation of recombinant PICH, Co-IP, DNA binding assay\",\n      \"pmids\": [\"25564610\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo consequences of PICH SUMOylation not fully mapped\", \"Functional SUMO sites on PICH not enumerated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Mapped three SUMO-interacting motifs to distinct functions—SIM3 for centromeric localization and others for bridge prevention—showing SUMO recognition partitions PICH's mitotic roles.\",\n      \"evidence\": \"Conditional expression of SIM-deficient PICH mutants with localization readouts\",\n      \"pmids\": [\"27230136\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"SUMO partners read by each SIM not individually identified\", \"UFB localization remained SIM-independent and unexplained\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Solved the crystal structure of a novel PICH TPR domain–BEND3 BEN domain interface, providing the first structural account of a PICH protein interaction in mitosis.\",\n      \"evidence\": \"Co-IP, in vitro interaction, 2.2 Å crystal structure with structure-guided mutagenesis\",\n      \"pmids\": [\"28977671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of BEND3 in PICH-dependent processes not established\", \"How TPR-BEN binding affects translocase activity unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Reconstituted a PICH-TOP3α machine generating reverse-gyrase-like positive supercoiling through PICH loop extrusion and TOP3α relaxation, defining a topological mechanism for sister-chromatid disjunction.\",\n      \"evidence\": \"In vitro reconstitution with purified PICH and TOP3α, magnetic tweezers\",\n      \"pmids\": [\"30936532\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo demonstration of supercoiling at UFBs absent\", \"Coordination with TopoIIα decatenation not integrated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed PICH in replication stress responses, showing TOP2A-SUMO-dependent recruitment to stalled forks where it acts downstream of HLTF/ZRANB3/SMARCAL1 to enable extensive fork reversal, extending PICH function beyond mitosis.\",\n      \"evidence\": \"Knockdown epistasis, EM fork reversal assay, PLA, Co-IP\",\n      \"pmids\": [\"33296677\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct topological substrate at forks not visualized\", \"Relationship to mitotic UFB function not reconciled\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed PICH translocase disperses SUMO2/3 foci and attenuates SUMOylated TopoIIα, linking PICH's enzymatic activity to clearance of SUMO-modified chromosomal proteins.\",\n      \"evidence\": \"AID-based PICH depletion, translocase-mutant rescue, in vitro SUMO-TopoIIα assay, IF\",\n      \"pmids\": [\"32877270\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of SUMO substrates remodeled by PICH incomplete\", \"Mechanism of SUMO-protein removal by translocation unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Visualized PICH as a tension- and ATP-dependent nucleosome remodeler that unwraps and slides histones, mechanistically explaining how UFBs become histone-free under spindle tension.\",\n      \"evidence\": \"Dual-trap optical tweezers with fluorescence imaging on nucleosome arrays\",\n      \"pmids\": [\"36433994\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Fate of displaced histones in vivo unknown\", \"Integration with TopoIIα/TOP3α decatenation not shown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked PICH loss to organismal phenotype, showing Pich-KO causes cytoplasmic dsDNA, cGAS-STING activation, and interferon-driven loss of fetal hematopoietic stem cells, rescued by cGAS or Ifnar1 deletion.\",\n      \"evidence\": \"Pich-KO mouse, HSC transplantation, cGAS/Ifnar1 double-KO rescue, dsDNA and IFN assays\",\n      \"pmids\": [\"35037428\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Source of cytoplasmic dsDNA (unresolved bridges vs micronuclei) not pinned\", \"Tissue specificity of the requirement unexplained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined synthetic-lethal and compensatory genetic relationships (FIRRM/FIGNL1 and RAD52) that create dependency on PICH for genome stability, identifying potential therapeutic vulnerabilities.\",\n      \"evidence\": \"Genome-wide CRISPR screens, Co-IP, UFB and RAD51/RAD52 foci, fork dynamics assays\",\n      \"pmids\": [\"37347663\", \"39561207\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct mechanistic interaction between PICH and these pathways unresolved\", \"Single-lab screen validations\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Implicated ERCC6L in oncogenic cell-cycle and transcriptional programs, forming a complex with RNA Pol II and ATF4 at CCNA1 and interacting with KIF4A to drive proliferation.\",\n      \"evidence\": \"Co-IP, ChIP, ATPase-mutant, organoid/PDX and conditional-KO mouse studies\",\n      \"pmids\": [\"37646571\", \"37667329\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether transcriptional roles are separable from translocase function unclear\", \"Direct DNA-binding at promoters versus indirect recruitment not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Resolved a dual role for PICH translocase in UFB resolution—generating single-stranded UFBs and stimulating TopoIIα—and tied PICH loss to DNA damage, micronuclei, p53 activation, and chromosomal rearrangements; also reconnected PICH to SAC via SUMO-protein remodeling and Bub1 control.\",\n      \"evidence\": \"Domain-mutant rescue (PICHK128A, BLM/RIF1-recruitment mutant), WGS, ssUFB IF, topo IIα assay, proteomics, Mad1/Bub1 IF\",\n      \"pmids\": [\"39704103\", \"39919802\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise molecular event producing ssUFBs undefined\", \"How SUMO-protein remodeling sets Bub1 levels mechanistically unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PICH's distinct biochemical activities—loop-extruding supercoiling with TOP3α, TopoIIα stimulation, nucleosome remodeling, and SUMO-protein dispersal—are spatially and temporally coordinated into a single coherent bridge-resolution program remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unified in vivo model linking the in vitro activities\", \"Order and hand-off between TopoIIα, TOP3α, BLM, and RIF1 at a single UFB undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [8, 10, 11, 15]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [10, 12, 13]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [7, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [11, 15, 17]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [20, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 1, 12]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [0, 1, 11, 24]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [16, 21, 23]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [16, 21]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PLK1\", \"BLM\", \"TOP2A\", \"TOP3A\", \"RIF1\", \"BEND3\", \"KIF4A\", \"ATF4\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}